Meta‐analysis of Pharmacokinetic/Pharmacodynamic Results of 3 Phase 1 Studies with Biosimilar Pegfilgrastim

A meta‐analysis using data from 3 phase 1 studies evaluated the pharmacokinetics (PK) and pharmacodynamics (PD) of Sandoz biosimilar versus US‐ and EU‐reference pegfilgrastim. The studies included a single‐dose, double‐blind, 3‐arm, parallel‐group study (study 1); a single‐dose, double‐blind, 2‐way...

Descripción completa

Detalles Bibliográficos
Autores principales: Gattu, Sreekanth, Wang, Jessie, Bellon, Anne, Schelcher, Celine, Nakov, Roumen, Arani, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290022/
https://www.ncbi.nlm.nih.gov/pubmed/34350732
http://dx.doi.org/10.1002/cpdd.1005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290022/
https://www.ncbi.nlm.nih.gov/pubmed/34350732
http://dx.doi.org/10.1002/cpdd.1005

Ejemplares similares